Lista de obras - Rafal Stec - Dominio Público Uruguay

Are primary renal cell carcinoma and metastases of renal cell carcinoma the same cancer?

artículo científico publicado en 2016

Axitinib in sequential therapy in metastatic renal cell carcinoma.

scientific article published on 20 December 2016

Biomarkers defining probability of receiving second-line targeted therapy in metastatic renal cell carcinoma.

artículo científico publicado en 2018

Chromophobe renal cell cancer--review of the literature and potential methods of treating metastatic disease.

artículo científico publicado en 2009

Clinical usefulness of PI3K/Akt/mTOR genotyping in companion with other clinical variables in metastatic renal cell carcinoma patients treated with everolimus in the second and subsequent lines

artículo científico publicado en 2015

Colorectal cancer in the course of familial adenomatous polyposis syndrome ("de novo" pathogenic mutation of APC gene): case report, review of the literature and genetic commentary

artículo científico publicado en 2010

Cystatin C as a parameter of glomerular filtration rate in patients with ovarian cancer.

artículo científico publicado en 2010

Cystatin C as a predictor factor in patients with renal cell carcinoma treated by everolimus.

artículo científico publicado en 2016

Editorial comment to Chromophobe renal cell carcinoma: a review of an uncommon entity

scientific article published on 04 September 2012

Feasibility and efficacy of capecitabine and FOLFIRI in patients aged 65 years and older with advanced colorectal cancer: a retrospective analysis

artículo científico publicado en 2009

Fuhrman Grade and Neutrophil-To-Lymphocyte Ratio Influence on Survival in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors

artículo científico publicado en 2016

Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapy

artículo científico publicado en 2020

Incorporating Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in Place of Neutrophil Count and Platelet Count Improves Prognostic Accuracy of the International Metastatic Renal Cell Carcinoma Database Consortium Model

artículo científico publicado en 2017

Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients

artículo científico publicado en 2016

Intensity of Nuclear Staining for Ki-67, p53 and Survivin as a New Prognostic Factor in Non-muscle Invasive Bladder Cancer

scientific article published on 19 June 2019

K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy

artículo científico publicado en 2012

Metastatic colorectal cancer in the elderly: An overview of the systemic treatment modalities (Review).

artículo científico publicado en 2010

Milestones in the treatment of hepatocellular carcinoma: A systematic review

artículo científico publicado en 2020

Mitomycin C and high-dose 5-fluorouracil with folinic acid as a therapeutic option for heavily pretreated patients with metastatic colorectal cancer: prospective phase II trial

artículo científico publicado en 2014

Molecular differences in the KRAS gene mutation between a primary tumor and related metastatic sites - case report and a literature review.

artículo científico publicado en 2010

Mutation of the PIK3CA gene as a prognostic factor in patients with colorectal cancer

artículo científico publicado en 2015

Neutrophil-to-lymphocyte Ratio, Platelet-to-lymphocyte Ratio, and C-reactive Protein as New and Simple Prognostic Factors in Patients With Metastatic Renal Cell Cancer Treated With Tyrosine Kinase Inhibitors: A Systemic Review and Meta-analysis.

artículo científico publicado en 2018

Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system.

artículo científico publicado en 2013

Prognostic Significance of Pancreatic Metastases from Renal Cell Carcinoma in Patients Treated with Tyrosine Kinase Inhibitors

artículo científico publicado en 2018

Prognostic significance of Wnt-1, β-catenin and E-cadherin expression in advanced colorectal carcinoma.

artículo científico publicado en 2011

Resistance to first line platinum paclitaxel chemotherapy in serous epithelial ovarian cancer: the prediction value of ERCC1 and Tau expression

artículo científico publicado en 2014

Role of WNT/β-Catenin Pathway as Potential Prognostic and Predictive Factors in Renal Cell Cancer Patients Treated With Everolimus in the Second and Subsequent Lines

artículo científico publicado en 2018

Selected protein expression in a new prognostic model for patients with non-muscle-invasive bladder cancer

scientific article published on 01 April 2020

Serous peritoneal psammocarcinoma with an aggressive course: a case and review of the literature.

artículo científico publicado en 2009

Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy.

artículo científico publicado en 2013

The Role of the Gut Microbiome in Colorectal Cancer: Where Are We? Where Are We Going?

scientific article published on 15 July 2019

The role of Tau protein in resistance to paclitaxel

artículo científico publicado en 2011

Lista de obras de Rafal Stec

Are primary renal cell carcinoma and metastases of renal cell carcinoma the same cancer?

Axitinib in sequential therapy in metastatic renal cell carcinoma.

Biomarkers defining probability of receiving second-line targeted therapy in metastatic renal cell carcinoma.

Chromophobe renal cell cancer--review of the literature and potential methods of treating metastatic disease.

Clinical usefulness of PI3K/Akt/mTOR genotyping in companion with other clinical variables in metastatic renal cell carcinoma patients treated with everolimus in the second and subsequent lines

Colorectal cancer in the course of familial adenomatous polyposis syndrome ("de novo" pathogenic mutation of APC gene): case report, review of the literature and genetic commentary

Cystatin C as a parameter of glomerular filtration rate in patients with ovarian cancer.

Cystatin C as a predictor factor in patients with renal cell carcinoma treated by everolimus.

Editorial comment to Chromophobe renal cell carcinoma: a review of an uncommon entity

Feasibility and efficacy of capecitabine and FOLFIRI in patients aged 65 years and older with advanced colorectal cancer: a retrospective analysis

Fuhrman Grade and Neutrophil-To-Lymphocyte Ratio Influence on Survival in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors

Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapy

Incorporating Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in Place of Neutrophil Count and Platelet Count Improves Prognostic Accuracy of the International Metastatic Renal Cell Carcinoma Database Consortium Model

Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients

Intensity of Nuclear Staining for Ki-67, p53 and Survivin as a New Prognostic Factor in Non-muscle Invasive Bladder Cancer

K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy

Metastatic colorectal cancer in the elderly: An overview of the systemic treatment modalities (Review).

Milestones in the treatment of hepatocellular carcinoma: A systematic review

Mitomycin C and high-dose 5-fluorouracil with folinic acid as a therapeutic option for heavily pretreated patients with metastatic colorectal cancer: prospective phase II trial

Molecular differences in the KRAS gene mutation between a primary tumor and related metastatic sites - case report and a literature review.

Mutation of the PIK3CA gene as a prognostic factor in patients with colorectal cancer

Neutrophil-to-lymphocyte Ratio, Platelet-to-lymphocyte Ratio, and C-reactive Protein as New and Simple Prognostic Factors in Patients With Metastatic Renal Cell Cancer Treated With Tyrosine Kinase Inhibitors: A Systemic Review and Meta-analysis.

Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system.

Prognostic Significance of Pancreatic Metastases from Renal Cell Carcinoma in Patients Treated with Tyrosine Kinase Inhibitors

Prognostic significance of Wnt-1, β-catenin and E-cadherin expression in advanced colorectal carcinoma.

Resistance to first line platinum paclitaxel chemotherapy in serous epithelial ovarian cancer: the prediction value of ERCC1 and Tau expression

Role of WNT/β-Catenin Pathway as Potential Prognostic and Predictive Factors in Renal Cell Cancer Patients Treated With Everolimus in the Second and Subsequent Lines

Selected protein expression in a new prognostic model for patients with non-muscle-invasive bladder cancer

Serous peritoneal psammocarcinoma with an aggressive course: a case and review of the literature.

Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy.

The Role of the Gut Microbiome in Colorectal Cancer: Where Are We? Where Are We Going?

The role of Tau protein in resistance to paclitaxel